Effects of Scalp Nerve Block on Postoperative Pain, Hemodynamics and Surgical Stress Response in Craniotomy Surgery
Launched by UMRANIYE EDUCATION AND RESEARCH HOSPITAL · Dec 22, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a method called scalp nerve block to see if it can help reduce pain after craniotomy surgery, which is a type of brain surgery. The researchers want to find out if giving this nerve block before the surgery (preincisional) is more effective at lowering the need for pain medication (like opioids) and reducing stress on the body compared to giving it after the surgery (postincisional).
To participate in this trial, you need to be between 18 and 65 years old and have a general health rating of ASA 1-3, which means you should be in relatively good health without serious medical conditions. Unfortunately, those with certain health issues, like high blood pressure, obesity, or a history of chronic pain, won't be eligible. If you join the study, you can expect to receive either the pre-surgery or post-surgery nerve block and be monitored for your pain levels and overall recovery. This trial is not yet recruiting, so details may change as it moves forward.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age range 18-65
- • ASA 1-3 score
- Exclusion Criteria:
- • Chronic hypertension
- • Arrhythmia
- • body mass index (BMI) over 40 kg/m2
- • Bleeding diathesis
- • Allergy
- • Serious cardiovascular, pulmonary, renal and hepatic disease
- • Local infection at the injection site
- • Alcohol and substance abuse
- • Neurological sequelae, mental retardation
- • GCS under 15
- • Patients admitted to the intensive care unit as intubated
- • Pregnancy
- • Those with a history of chronic pain
- • Scalp infection
- • Use of vozoactive drugs
- • Patients with previous craniotomy
- • Patients who do not accept
About Umraniye Education And Research Hospital
Umraniye Education and Research Hospital is a leading healthcare institution dedicated to advancing medical research and education. Located in Istanbul, Turkey, the hospital is renowned for its commitment to providing high-quality patient care while fostering innovation in clinical trials. As a clinical trial sponsor, Umraniye Education and Research Hospital emphasizes ethical standards, rigorous scientific methodology, and collaboration with healthcare professionals and researchers. The institution aims to contribute to the development of new therapies and improve health outcomes through its robust research programs and a multidisciplinary approach to clinical studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Umraniye, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported